SpringerBriefs in Health Care Management and Economics
cover

The Indian Pharmaceutical Industry

Impact of Changes in the IPR Regime

Authors: Mitsumori, Yaeko

  • Explains that the Indian pharmaceutical industry is No. 4 in the world in volume and its development is being carefully watched
  • Explains why the Indian pharmaceutical industry successfully expanded even after the introduction of product patents
  • Provides information on the unique article “3d” in the Indian Patent Act and how it allows the Indian Patent Office to reject some patents that have been granted in the rest of the world
see more benefits

Buy this book

eBook $39.99
price for USA in USD
  • ISBN 978-981-10-6790-7
  • Digitally watermarked, DRM-free
  • Included format: EPUB, PDF
  • ebooks can be used on all reading devices
  • Immediate eBook download after purchase
Softcover $54.99
price for USA in USD
  • ISBN 978-981-10-6789-1
  • Free shipping for individuals worldwide
  • Institutional customers should get in touch with their account manager
  • Covid-19 shipping restrictions
  • Usually ready to be dispatched within 3 to 5 business days, if in stock
About this book

This study analyzes the impact of the revision of the Indian Patent Act (2005) on the Indian pharmaceutical industry, which has been achieving healthy growth over the past 30 to 40 years or more. As of 2005, the Indian pharmaceutical industry was ranked as No. 4 in the world in terms of volume and 15th in terms of value. WTO/TRIPS required India to revise its patent law, however, and to introduce product patents in the pharmaceutical field. Many not only in India but also in the world had argued that the local pharmaceutical industry could deteriorate once a strong patent law (such as a product patent) was introduced. However, the Indian pharmaceutical industry has continued to develop rapidly even after the revision of the patent law in 2005. This present study started with efforts to work out the reason the Indian pharmaceutical industry successfully expanded even after the introduction of product patents. The study found that a unique article (the so-called '3-d‘) inserted in the Patent Act 2005  might have played a role in diminishing or preventing a negative impact from the introduction of a strong patent system, such as a product patents.  The study also considers that a change of the business model adopted by the Indian pharmaceutical industry might have contributed to diminishing the effect of the negative impact from the introduction of a strong patent law.

This study also covers recent developments in India regarding intellectual property rights and the pharmaceutical industry. One is India’s very first compulsory license granted to an Indian pharmaceutical company, Natco, against the large German pharmaceutical firm Bayer; and the second is the Supreme Court decision on Novartis’ Gleevec. The study analyzes the fundamental problems that caused these two events: access to medicine and gaps in the concept of intellectual property in the pharmaceutical industry. As possible solutions to these fundamental issues, this book explores the ideas of voluntary licensing and tiered pricing.

Table of contents (8 chapters)

Table of contents (8 chapters)
  • Introduction

    Pages 1-7

    Mitsumori, Yaeko

  • Historical Background and Current Status of Indian Pharmaceutical Industry and Indian Patents Regime

    Pages 9-35

    Mitsumori, Yaeko

  • Research Subject and Methodology

    Pages 37-40

    Mitsumori, Yaeko

  • Analysis of Preceding Studies

    Pages 41-51

    Mitsumori, Yaeko

  • Analysis of Indian Pharmaceutical Industry Indicators: Data Analysis

    Pages 53-74

    Mitsumori, Yaeko

Buy this book

eBook $39.99
price for USA in USD
  • ISBN 978-981-10-6790-7
  • Digitally watermarked, DRM-free
  • Included format: EPUB, PDF
  • ebooks can be used on all reading devices
  • Immediate eBook download after purchase
Softcover $54.99
price for USA in USD
  • ISBN 978-981-10-6789-1
  • Free shipping for individuals worldwide
  • Institutional customers should get in touch with their account manager
  • Covid-19 shipping restrictions
  • Usually ready to be dispatched within 3 to 5 business days, if in stock
Loading...

Bibliographic Information

Bibliographic Information
Book Title
The Indian Pharmaceutical Industry
Book Subtitle
Impact of Changes in the IPR Regime
Authors
Series Title
SpringerBriefs in Health Care Management and Economics
Copyright
2018
Publisher
Springer Singapore
Copyright Holder
The Author(s)
eBook ISBN
978-981-10-6790-7
DOI
10.1007/978-981-10-6790-7
Softcover ISBN
978-981-10-6789-1
Series ISSN
2193-1704
Edition Number
1
Number of Pages
VII, 120
Number of Illustrations
8 b/w illustrations, 28 illustrations in colour
Topics